Active transdermal medicament patch

• US 20080214985A1
• Filed: 01/18/2008
• Published: 09/04/2008
• Est. Priority Date: 02/02/2007
• Status: Abandoned Application

• Current Assignee: ActivaTek Inc. (North Coast Medical, Inc.)
• Original Assignee: ActivaTek Inc. (North Coast Medical, Inc.)
• Inventors: Yanaki, Jamal S.
• Application Number:
  US12/009,409
• Publication Number:
  US 20080214985A1
• Time in Patent Office: Days
• US Class Current: 604/20
• CPC Class Codes: A61K 9/0009 involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis microelectromechanical systems A61K9/0097
• CPC Class Codes: A61K 9/7023 Transdermal patches and similar drug-containing composite devices, e.g. cataplasms galenical aspects of iontophoretic devices A61K9/0009; microneedle arrays A61K9/0021; buccal patches A61K9/006
• CPC Class Codes: A61N 1/303 Constructional details electrodes for external use A61N1/0428

Abstract

An active transdermal medicament patch includes a planar substrate with a therapeutic face releasably retainable against the skin of a patient. A return electrode and a medicament matrix susceptible to permeation by medicament are secured at separated locations on the therapeutic face. Each electrically conductively engages the skin, when the substrate is retained thereon. A power source carried on the substrate is electrically coupled between the medicament matrix and a programmed microprocessor also carried on the substrate. A substantially invariant voltage presented at an output contact of the microprocessor is applied during a predetermined therapy period across the skin between the medicament matrix and the return electrode, inducing transcutaneous migration of medicament into the skin at a substantially constant rate. A light-emitting diode carried on the substrate and coupled to the microprocessor communicates that the patch is operating.

Claims

1. An active transdermal medicament patch comprising:

(a) a flexible, planar biocompatible substrate having on one side thereof a therapeutic face configured for releasable retention against the skin of a patient;

(b) a planar medicament matrix secured to said therapeutic face of said substrate, said medicament matrix being susceptible to permeation by medicament, and said medicament matrix effecting electrically conductive engagement with the skin of the patient when said substrate is retained thereupon;

(c) a power source carried on said substrate and electrically coupled to said medicament matrix; and

(d) voltage means carried non-removably on said substrate and driven by said power source for generating a substantially invariant voltage output during a predetermined therapy period and for applying said voltage output across said medicament matrix and the skin of the patient engaged thereby.

2. A medicament patch as recited in claim 1, further comprising a return electrode secured to said therapeutic face of said substrate, said return electrode effecting electrically conductive engagement with the skin of the patient when said substrate is retained thereupon.

3. A medicament patch as recited in claim 2, wherein said power source is electrically coupled between said voltage means and said return electrode.

4. A medicament patch as recited in claim 1, wherein said power source is electrically coupled between said voltage means and said medicament matrix.

5. A medicament patch as recited in claim 1, wherein medicament used to permeate said medicament matrix has a negative polarity.

6. A medicament patch as recited in claim 1, wherein medicament used to permeate said medicament matrix has a positive polarity.

7. A medicament patch as recited in claim 1, wherein said power source comprises a battery carried on said substrate.

8. A medicament patch as recited in claim 7, wherein said battery is secured non-removably to said substrate.

9. A medicament patch as recited in claim 1, further comprising activity indication means carried non-removably on said substrate for communicating to a user when said voltage means is operating.

10. A medicament patch as recited in claim 9, wherein said voltage means comprises:

(a) a timer active during said therapy period;

(b) a voltage regulator, said voltage regulator converting electrical potential from said power source into said substantially invariant voltage output of said voltage means; and

(d) a driver for said activity indication means.

11. A medicament patch as recited in claim 1, further comprising a switch carried on substrate, said switch permitting a user to initiate operation of said voltage means.

12. A medicament patch as recited in claim 11, wherein said switch comprises a user-operated pull tab.

13. An active transdermal medicament patch comprising:

(a) a flexible, planar biocompatible substrate having on one side thereof a therapeutic face configured for releasable retention against the skin of a patient;

(b) a medicament matrix secured to said therapeutic face of said substrate, said medicament matrix effecting electrically conductive engagement with the skin of the patient when said substrate is retained thereupon;

(c) a power source carried on said substrate and electrically coupled to said medicament matrix;

(d) a voltage regulator carried non-removably on said substrate and electrically coupled to said power source, said voltage regulator converting electrical potential from said power source into a substantially invariant voltage output of said voltage regulator;

(e) a timer carried non-removably on said substrate and active during a predetermined therapy period wherein said voltage output of said voltage regulator is applied across said medicament matrix and the skin of the patient engaged thereby; and

(f) activity indication means carried non-removably on said substrate for advising a user when said timer is active.

14. A medicament patch as recited in claim 13, wherein said activity indication means comprises a visual indicator.

15. A medicament patch as recited in claim 14, wherein said visual indicator comprises a light-emitting diode.

16. A medicament patch as recited in claim 15, wherein said light-emitting diode operates intermittently during said therapy period.

17. A medicament patch as recited in claim 13, further comprising a driver for said activity indication means.

18. An active transdermal medicament patch comprising:

(a) a flexible, planar biocompatible substrate having on one side thereof a therapeutic face configured for releasable retention against the skin of a patient;

(b) a medicament matrix secured to said therapeutic face of said substrate, said medicament matrix effecting electrically conductive engagement with the skin of the patient when said substrate is retained thereupon;

(c) a return electrode secured to said therapeutic face of said substrate, said return electrode effecting electrically conductive engagement with the skin of the patient when said substrate is retained thereupon

(c) a power source carried on said substrate and electrically coupled to said medicament matrix; and

(d) a programmed microprocessor carried non-removably on said substrate and having an input contact electrically coupled to said power source and an output contact electrically coupled to said return electrode, said. microprocessor converting electrical potential from said power source into a substantially invariant voltage output presented a said output contact of said microprocessor.

19. A medicament patch as recited in claim 18, further comprising a sensing resistor electrically coupled between said output contact of said microprocessor and a current monitoring contact of said microprocessor.

20. A medicament patch as recited in claim 18, further comprising a light-emitting diode series-connected with a bias resistor between said input contact of said microprocessor and an activity indication contact of said microprocessor.